OptimizeRx CFO sells $18,751 in shares
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
OPTIMIZERx Corp (OPRX)
OPTIMIZERx Corp stock price live, this page displays NASDAQ OPRX stock exchange data. View the OPRX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the OPTIMIZERx Corp real time stock price chart below.
What Is the OPTIMIZERx Corp Stock Price Today?
The OPTIMIZERx Corp stock price today is 12.74.
What Is the Stock Symbol for OPTIMIZERx Corp?
The stock symbol for OPTIMIZERx Corp is "OPRX."
What Stock Exchange Does OPTIMIZERx Corp Trade On?
OPTIMIZERx Corp is listed and trades on the NASDAQ stock exchange.
Is OPTIMIZERx Corp a Good Stock to Buy?
Determining whether OPTIMIZERx Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OPRX quote. (ISIN: US68401U2042)
What Is the OPTIMIZERx Corp Stock Price Today?
The OPTIMIZERx Corp stock price today is 12.74.
What Is the Stock Symbol for OPTIMIZERx Corp?
The stock symbol for OPTIMIZERx Corp is "OPRX."
What Stock Exchange Does OPTIMIZERx Corp Trade On?
OPTIMIZERx Corp is listed and trades on the NASDAQ stock exchange.
Is OPTIMIZERx Corp a Good Stock to Buy?
Determining whether OPTIMIZERx Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OPRX quote. (ISIN: US68401U2042)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.65
13.18
52 wk Range
3.99
22.25
OPRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.6513.18
52 wk Range
3.9922.25
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
OPRX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
24.33
Upside
+91.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings downwards for the upcoming period
- Optimizerx Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Optimizerx Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Halozyme elects Jim Lang to board of directors
- Investing.com
- OptimizeRx CFO sells $18,751 in shares
- Investing.com
- Halozyme elects Jim Lang to board of directors
- Investing.com
- Optimizerx Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Optimizerx Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
OPTIMIZERx Corp Company Profile
OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers’ target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. It also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is based in Waltham, Massachusetts.
OPTIMIZERx Corp SWOT Analysis
Digital Health Pionee | OptimizeRx leads in EHR-integrated pharmaceutical messaging, showcasing strong financial performance and strategic shifts towards subscription-based models |
Market Dynamics | Explore the company's navigation of DTC challenges and its potential for growth in an evolving digital healthcare landscape |
Financial Outlook | Delve into OptimizeRx's raised 2025 guidance, with revenue projections between $101-106 million and adjusted EBITDA of $13-15 million |
Analyst Perspectives | Discover varied analyst views on OptimizeRx's future, with price targets ranging from $6 to $14, reflecting diverse opinions on the company's growth potential |
OPTIMIZERx Corp Earnings Call Summary for Q3/2025
- OptimizeRx reported Q3 2025 EPS of $0.20, exceeding forecasts by 400%, with revenue of $26.1 million above expected $23.83 million, driving stock up 1.98% in aftermarket trading.
- The company is successfully transitioning to a subscription-based revenue model, with the majority of business now coming from renewals, enhancing financial stability.
- Gross margins are expanding and stabilizing in the upper 50s to low 60s range, despite slight increases in operational expenses due to performance-based bonuses.
- For 2026, OptimizeRx forecasts 60 basis points expansion in EBITDA margins, adopting a conservative approach to ensure predictable revenue growth.
- CEO Steve Silvestro highlighted a robust RFP season with more targeted requests, while strategic partnerships including one with Lamar Advertising are driving growth.
Last Updated: 2025-11-06, 06:56 p/m
Read Full TranscriptCompare OPRX to Peers and Sector
Metrics to compare | OPRX | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipOPRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 6,984.8x | −0.8x | −0.6x | |
PEG Ratio | 69.75 | −0.01 | 0.00 | |
Price/Book | 1.9x | 1.3x | 2.6x | |
Price / LTM Sales | 2.2x | 1.2x | 3.2x | |
Upside (Analyst Target) | 88.4% | 67.8% | 41.8% | |
Fair Value Upside | Unlock | 36.7% | 5.1% | Unlock |
Analyst Ratings
6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 24.33
(+91.00% Upside)
Earnings
Latest Release
Nov 06, 2025
EPS / Forecast
0.20 / 0.04
Revenue / Forecast
26.10M / 23.83M
People Also Watch
FAQ
What Is the OPTIMIZERx (OPRX) Stock Price Today?
The OPTIMIZERx stock price today is 12.74
What Stock Exchange Does OPTIMIZERx Trade On?
OPTIMIZERx is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for OPTIMIZERx?
The stock symbol for OPTIMIZERx is "OPRX."
What Is the OPTIMIZERx Market Cap?
As of today, OPTIMIZERx market cap is 237.48M.
What Is OPTIMIZERx's Earnings Per Share (TTM)?
The OPTIMIZERx EPS (TTM) is 0.00.
When Is the Next OPTIMIZERx Earnings Date?
OPTIMIZERx will release its next earnings report on Feb 19, 2026.
From a Technical Analysis Perspective, Is OPRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has OPTIMIZERx Stock Split?
OPTIMIZERx has split 3 times.
How Many Employees Does OPTIMIZERx Have?
OPTIMIZERx has 129 employees.
What is the current trading status of OPTIMIZERx (OPRX)?
As of Dec 24, 2025, OPTIMIZERx (OPRX) is trading at a price of 12.74, with a previous close of 12.74. The stock has fluctuated within a day range of 12.65 to 13.18, while its 52-week range spans from 3.99 to 22.25.
What Is OPTIMIZERx (OPRX) Price Target According to Analysts?
The average 12-month price target for OPTIMIZERx is USD24.33333, with a high estimate of USD32 and a low estimate of USD17. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +91.00% Upside potential.
What Is the OPRX After Hours Price?
OPRX's last after hours stock price is 12.70, the stock has decreased by -0.04, or -0.31%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.